Molecular weight-dependent anticoagulation activity of sulfated cellulose derivatives

Cellulose

Volumn 17, Issue 5, 2010, Pages 953-961

  Wang, Zhao Mei ^a,b,c   Xiao, Kai Jun ^a   Li, Lin ^a   Wu, Jian Yong ^c  

^a SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

^b GUANGZHOU INSTITUTE OF CHEMISTRY   (China)

^c HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

Author keywords

Acidic degradation; Anticoagulation; Ionic liquid; Molecular weight; Sulfated cellulose derivatives

Indexed keywords

ACIDIC DEGRADATION; ACIDIC SOLUTIONS; ACTIVITY ASSAYS; ANTICOAGULANT PROPERTIES; ANTICOAGULATION; CELLULOSE SULFATES; CLOTTING TIME; COAGULATION FACTOR; COAGULATION TIME; DEGREE OF SUBSTITUTION; HUMAN PLASMAS; IN-VITRO; IN-VITRO ASSAYS; IN-VIVO; MAJOR FACTORS; MICROCRYSTALLINE CELLULOSE; NEGATIVE CORRELATION; POSITIVE CORRELATIONS;

ASSAYS; CELLULOSE DERIVATIVES; COAGULATION; DEGRADATION; IONIC LIQUIDS; IONS; MOLECULAR WEIGHT;

CELLULOSE;

CELLULOSE DERIVATIVES; COAGULANTS; DEGRADATION; MOLECULAR WEIGHT;

EID: 77956875518     PISSN: 09690239     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10570-010-9441-7     Document Type: Article

References (23)

1. Alban S, Franz G (1994) Anticoagulant activity of curdlan sulfates in dependence on their molecular weight. Pure Appl Chem 66: 2403-2406.
2. Anderson LO, Barrowcliffe TW, Holmer E (1979) Molecular weight dependency of the heparin potentiated inhibition of thrombin and activated factor X: effect of heparin neutralization in plasma. Thrombosis Res 5: 531-541.
3. Baumann H (2001) The role of regioselectively sulfated and acetylated polysaccharide coatings of biomaterials for reducing platelet and plasma protein adhesion. Semin Thromb Hemost 27: 445-463.
4. Gericke M, Liebert T, Heinze T (2009) Interaction of ionic liquids with polysaccharides, 8-synthesis of cellulose sulfates suitable for polyelectrolyte complex formation. Macromol Biosci 9: 343-353.
5. Groth T, Wagenknecht W (2001) Anticoagulant potential of regioselective derivatized cellulose. Biomaterials 22: 2719-2729.
6. Hirsh J, Warkentin TE, Shaughnessy SG, Anand SS, Halperin JL, Raschke R, Granger C, Ohrman EM, Dalen JE (2001) Heparin and low-molecular-weight heparin mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest 119: 64-94.
7. Huang RH, Du YM, Yang JH (2003) Preparation and in vitro anticoagulant activities of alginate sulfate and its quaterized derivatives. Carbohydr Polym 52: 19-24.
8. Laurent TC, Tengblad A, Thunberg L, Höök M, Lindahl U (1978) The molecular-weight-dependence of the anti-coagulant activity of heparin. Biochem J 175: 691-701.
9. Lin CZ, Guan HS, Li HH, Yu GL, Gu CX, Li GQ (2007) The influence of molecular mass of sulfated propylene glycol ester of low-molecular-weight alginate on anticoagulant activities. Eur Polym J 43: 3009-3015.
10. Linhardt RJ, Gunay NS (1999) Production and chemical processing of low molecular weight heparins. Semin Thromb Hemost 25: 5-16.
11. Majdoub H, Mansour MB, Chaubet F, Roudesli MS, Maaroufi RM (2009) Anticoagulant activity of a sulfated polysaccharide from the green alga Arthrospira platensis. Biochim Biophys Acta 1790: 1377-1381.
12. Mourão PAS, Pereira MS (1999) Searching for alternatives to heparin sulfated fucans from marine invertebrates. Trends Cardiovasc Med 9: 225-232.
13. Nardella A, Chaubet F, Boisson C (1996) Anticoagulant low molecular weight fucans produced by radical process and ion exchange chromatography of high molecular weight fucans extracted from the brown seaweed Ascophyllum nodosum. Carbohydr Res 289: 201-208.
14. 13C-NMR spectroscopy. Prog Polym Sci 19: 29-78.
15. Nishino T, Aizu Y, Nagumo T (1991) The influence of sulfate content and molecular weight of a fucan sulfate from the brown seaweed Ecklonia kurome on its antithrombin activity. Thromb Res 64: 723-731.
16. Pushpamali WA, Nikapitiya C, Zoysa MD, Whang I, Kim SJ, Lee J (2008) Isolation and purification of an anticoagulant from fermented red seaweed Lomentaria catenata. Carbohydr Polym 73: 274-279.
17. Radoff S, Danishefsky I (1984) Location on heparin of the oligosaccharide section essential for anticoagulant activity. J Biol Chem 259: 166-172.
18. Scully MF, Kakkar VV (1991) Identification of heparin cofactor II as the principle plasma cofactor for pentosan polysulfate (SP54). Thromb Haemost 17: 181-185.
19. Spyropoulos AC (2008) Brave new world: the current and future use of novel anticoagulants. Thromb Res 123: S29-S35.
20. Vikhoreva G, Bannikova G, Stolbushkina P, Panov A, Drozd N, Makarov V, Varlamov V, Galbraikh L (2005) Preparation and anticoagulant activity of a low-molecular-weight sulfated chitosan. Carbohydr Polym 62: 327-332.
21. Wang ZM, Li L, Xiao KJ, Wu JY (2009) Homogeneous sulfation of bagasse cellulose in an ionic liquid and anticoagulation activity. Bioresour Technol 100: 1687-1690.
22. Young E, Wells P, Holloway S, Weitz J, Hirsh J (1994) Ex-vivo and in vitro evidence that low molecular weight heparins exhibit less binding to plasma proteins than unfractionated heparin. Thromb Haemost 71: 300-304.
23. Zúñiga EA, Matsuhiro B, Mejías E (2006) Preparation of a low-molecular weight fraction by free radical depolymerization of the sulfated galactan from Schizymenia binderi (Gigartinales, Rhodophyta) and its anticoagulant activity. Carbohydr Polym 66: 208-215.